Global Trade Alert
Global Trade Alert

Back to state act

United States of America: Agreement with Boehringer Ingelheim on Most-Favoured-Nation drug pricing and tariff exemption

Description

On 19 December 2025, the U.S. Administration announced reaching an agreement with Boehringer Ingelheim. Under the agreement, Boehringer Ingelheim will be exempt from potential Section 232 tariffs on p...

Sign in to see full description

Intervention Details

Intervention Type

Tax or social insurance relief

MAST Chapter

Tariff measures

Implementation date

31 Jul 2026

Revocation date

20 Jan 2029

Implementation level

National

Affected flow

Inward

Announced as temporary

No

Eligible firms

firm-specific

Affected Trading Partners

Graph

Table

Affected Sectors

Sign in to access 1 sectors

Affected Products

Sign in to access 5 products

Threads

See all

This intervention is not part of any Thread yet.